agilon health, inc. (AGL) stock
AGLNYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
$90.53−24.67 (-21.41%)
Close on Nov 18, 2026Market cap $1.52BP/E –Yield –
agilon health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
agilon health's operating income for the twelve months ending Jun 30, 2026 was -$309.33M. For fiscal 2025 it was -$463.24M. The highest annual figure on record is -$56.67M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$463.24M | – |
| FY2024 | Dec 31, 2024 | -$292.13M | – |
| FY2023 | Dec 31, 2023 | -$232.13M | – |
| FY2022 | Dec 31, 2022 | -$105.38M | – |
| FY2021 | Dec 31, 2021 | -$372.24M | – |
| FY2020 | Dec 31, 2020 | -$56.67M | – |
| FY2019 | Dec 31, 2019 | -$106.57M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.77M | – |
| Q1 FY2026 | Mar 31, 2026 | $4.00M | – |
| Q4 FY2025 | Dec 31, 2025 | -$193.83M | – |
| Q3 FY2025 | Sep 30, 2025 | -$131.27M | – |
| Q2 FY2025 | Jun 30, 2025 | -$116.03M | – |
| Q1 FY2025 | Mar 31, 2025 | -$22.11M | – |
| Q4 FY2024 | Dec 31, 2024 | -$108.10M | – |
| Q3 FY2024 | Sep 30, 2024 | -$133.51M | – |
| Q2 FY2024 | Jun 30, 2024 | -$43.34M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.18M | -1821.3% |
| Q4 FY2023 | Dec 31, 2023 | -$164.30M | – |
| Q3 FY2023 | Sep 30, 2023 | -$39.29M | – |
| Q2 FY2023 | Jun 30, 2023 | -$28.96M | – |
| Q1 FY2023 | Mar 31, 2023 | $417.00K | – |
| Q4 FY2022 | Dec 31, 2022 | -$54.07M | – |
| Q3 FY2022 | Sep 30, 2022 | -$29.52M | – |
| Q2 FY2022 | Jun 30, 2022 | -$21.05M | – |
| Q1 FY2022 | Mar 31, 2022 | -$743.00K | – |
| Q4 FY2021 | Dec 31, 2021 | -$26.16M | – |
| Q3 FY2021 | Sep 30, 2021 | -$35.60M | – |
| Q2 FY2021 | Jun 30, 2021 | -$298.36M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.12M | – |
| Q4 FY2020 | Dec 31, 2020 | -$39.74M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.84M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.25M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.83M | – |
See a number that looks wrong?